Prof. Nikolaos Grigoriadis on immunopathology of NMOSD
“NMOSD is a true astrocytopathy,” says Prof. Nikolaos Grigoriadis, as he outlines the immune mechanisms behind this distinct and highly targeted disease process.
In this focused interview from EAN 2025, Prof. Nikolaos Grigoriadis unpacks the immunopathological hallmarks of neuromyelitis optica spectrum disorder (NMOSD). He discusses how aquaporin-4 antibodies trigger astrocyte injury, the role of complement activation, and why NMOSD is now recognised as a distinct astrocytopathy—shaping the development of highly targeted therapies.
Curious to learn more about the expert behind this interview?
Visit Nikolaos Grigoriadis’s full biography for more insights into her expertise.
